Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 6,996 | 186 | 1,371 | N/A |
| Receivables | 645 | 648 | 328 | N/A |
| TOTAL | $7,765 | $849 | $1,900 | $N/A |
| Non-Current Assets | ||||
| Intangibles | 16,514 | 16,514 | 16,514 | 0 |
| Other Non-Current Assets | 192 | 0 | 0 | 0 |
| TOTAL | $16,706 | $16,514 | $16,514 | $N/A |
| Total Assets | $24,470 | $17,363 | $18,414 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 692 | 824 | 310 | 0 |
| TOTAL | $700 | $824 | $310 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 160 | 0 | 0 | 0 |
| TOTAL | $160 | $N/A | $N/A | $N/A |
| Total Liabilities | $861 | $824 | $310 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 10,747 | N/A | N/A | N/A |
| Common Shares | 11 | 9 | 8 | N/A |
| Retained earnings | -21,276 | -13,598 | -1,158 | N/A |
| Other shareholders' equity | 42 | 4,683 | 82 | 0 |
| TOTAL | $23,610 | $16,540 | $18,104 | $N/A |
| Total Liabilities And Equity | $24,470 | $17,363 | $18,414 | $0 |